ClinicalTrials.Veeva

Menu

Outcomes of a Novel Technique Minimal Scar Mastectomy

K

KK Women's and Children's Hospital

Status

Enrolling

Conditions

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Treatments

Procedure: nipple sparing mastectomy without reconstruction

Study type

Observational

Funder types

Other

Identifiers

NCT06676761
IRB 2020/2147

Details and patient eligibility

About

Nipple sparing mastectomy is oncologically safe and has a good cosmetic outcome. However, nipple sparing mastectomy was conventionally performed with reconstruction. Minimal scar mastectomy (MSM) is a novel technique which could allow women, with non-ptotic breasts, who do not want reconstruction, to conserve their nipple areolar complex (NAC) and avoid the transverse scar associated with modified radical mastectomy. This is the first study on the oncologic and surgical outcomes of MSM.

Enrollment

100 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: breast cancer patients who opted for minimal scar mastectomy -

Exclusion Criteria: breast cancer patients who underwent conventional mastectomy

Trial design

100 participants in 1 patient group

nipple sparing mastectomy without reconstruction
Description:
nipple sparing mastectomy without reconstruction
Treatment:
Procedure: nipple sparing mastectomy without reconstruction

Trial contacts and locations

2

Loading...

Central trial contact

Geok hoon Lim

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems